An Extensive Application for All Targeted Therapy Options
A 520-gene panel that covers cancer related genes targeted by commercialized and investigational drugs.
Enables detection of mutations (SNV, InDel, CNV, fusion, MSI, DDR, MMR, and TMB) associated with pan-solid tumors.
An all-in-one genomic testing solution for immunotherapy and targeted therapy.
Key Features and Benefits
Performance Validations


Note: Different mutation types demonstrated a consistent >97% sensitvity and >95% specificity in clinical sample validation tests.


Clinical Trial Studies


Taking part in more than 110 clinical trial assays including CS 1001 and Tislelizumab (4 CDx and 9 Pilot Stidies)



Activating mutations in PIK3CA and AKTI and inactivating alterations in PTEN genes were determined centrally (after randomization) by means of next-generation sequencing with the use of the Foundation One CDx assay (Foundation Medicine) in all countries except China (OncoScreen® Plus,Burning Rock Biotech).


OncoScreen® Plus has been included in 165 SCI publications,the accumulated impact factor has reached 1097,more than 20 papers have IF>10,including one in The New England Journal of Medicine.(IF=158)

Contact Our Biopharma Team to Learn More
Biomarker Discovery & Translational Research
Clinical Trial Design & Patient Recruitment
Global Capabilities for Clinical Studies
CDx Development & Commercialization
Genomic Data Solutions
ctDNA Monitoring Portfolio
Other
I also want to receive general marketing communications from Burning Rock Dx in addition to the specific information requested here. You may unsubscribe from receiving such general marketing communications at any time.
*Required
By submitting this form, or by checking the box above the “Submit” button (if applicable), you agree that your information will be processed according to Burning Rock’s privacy policy to provide you with the information and/or general marketing communications (if applicable) you have requested here. Burning Rock Dx is committed to protecting and respecting your privacy.
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."